RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $566,897 | +129.5% | 103,484 | +309.7% | 0.00% | – |
| Q4 2021 | $247,000 | -44.6% | 25,259 | +1.1% | 0.00% | – |
| Q3 2021 | $446,000 | -31.1% | 24,972 | -5.7% | 0.00% | -100.0% |
| Q2 2021 | $647,000 | +11.7% | 26,488 | +21.2% | 0.00% | 0.0% |
| Q1 2021 | $579,000 | +204.7% | 21,860 | -12.6% | 0.00% | – |
| Q4 2020 | $190,000 | +58.3% | 25,021 | +4.0% | 0.00% | – |
| Q3 2020 | $120,000 | -21.1% | 24,048 | 0.0% | 0.00% | – |
| Q2 2020 | $152,000 | +38.2% | 24,048 | -2.6% | 0.00% | – |
| Q1 2020 | $110,000 | -49.8% | 24,702 | +6.9% | 0.00% | – |
| Q4 2019 | $219,000 | +15.3% | 23,097 | -3.0% | 0.00% | – |
| Q3 2019 | $190,000 | -47.7% | 23,812 | +3.2% | 0.00% | – |
| Q2 2019 | $363,000 | +48.8% | 23,078 | +70.9% | 0.00% | – |
| Q1 2019 | $244,000 | – | 13,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |